← SynDRA
DINACICLIB
SynDRA canonical compound SYN0030043 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | CDK1 |
|---|
| Mechanism of action | CDK inhibitor |
|---|
All known targets
- CDK1
- CDK2
- CDK9
- CDK5
- CCNT1
Mechanisms of action (all sources)
- cyclin-dependent kinase inhibitor
- CDK1 INHIBITOR
- Cyclin-dependent kinase 1 inhibitor
- CDK2 INHIBITOR
- Cyclin-dependent kinase 2 inhibitor
- CDK5 INHIBITOR
- Cyclin-dependent kinase 5 inhibitor
- CDK9 INHIBITOR
- Cyclin-dependent kinase 9 inhibitor
Cross-references
Synonyms
- Mk-7965
- SCH-727965
- SCH727965
- Dinaciclib (SCH727965)
- MK-7965
- (S)-3-(((3-ethyl-5-(2-(2-hydroxyethyl)piperidin-1-yl)pyrazolo[1,5-a]pyrimidin-7-yl)amino)methyl)pyridine 1-oxide
- (2S)-1-[3-Ethyl-7-[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-2-piperidineethanol
- 2-[(2S)-1-[3-ethyl-7-[(1-oxidopyridin-1-ium-3-yl)methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-2-yl]ethanol
- 1-[3-Ethyl-7[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-2(s)-piperidineethanol
- DINACICLIB [INN]
- Dinaciclib (USAN/INN)
- DINACICLIB [USAN]
- 4V8ECV0NBQ
- DINACICLIB [WHO-DD]
- MLS006011034
- GTPL7379
- CHEMBL2103840
- SCHEMBL12048446
- CHEBI:95060
- BDBM50139171
- MFCD16037702
- NSC747135
- NSC764036
- NSC800091
- s2768
- ZINC34894449
- AKOS030526898
- CCG-268610
- CS-0541
- DB12021
- NSC-727135
- NSC-747135
- NSC-764036
- NSC-800091
- AC-32835
- AS-17017
- HY-10492
- SMR004702827
Look up DINACICLIB in the interactive SynDRA portal →